Nasal xenobiotic metabolizing enzymes (XMEs) are important
for
the sense of smell because they influence odorant availability and
quality. Since the major part of the human nasal cavity is lined by
a respiratory mucosa, we hypothesized that this tissue contributed
to nasal odorant metabolism through XME activity. Thus, we built human
respiratory tissue models and characterized the XME profiles using
single-cell RNA sequencing. We focused on the XMEs dicarbonyl and l-xylulose reductase, aldehyde dehydrogenase (ALDH) 1A1, and
ALDH3A1, which play a role in food odorant metabolism. We demonstrated
protein abundance and localization in the tissue models and showed
the metabolic activity of the corresponding enzyme families by exposing
the models to the odorants 3,4-hexandione and benzaldehyde. Using
gas chromatography coupled with mass spectrometry, we observed, for
example, a significantly higher formation of the corresponding metabolites
4-hydroxy-3-hexanone (39.03 ± 1.5%, p = 0.0022),
benzyl alcohol (10.05 ± 0.88%, p = 0.0008),
and benzoic acid (8.49 ± 0.57%, p = 0.0004)
in odorant-treated tissue models compared to untreated controls (0
± 0, 0.12 ± 0.12, and 0.18 ± 0.18%, respectively).
This is the first study that reveals the XME profile of tissue-engineered
human respiratory mucosa models and demonstrates their suitability
to study nasal odorant metabolism.